In humans, HSP10 autoantibodies have been detected in a high proportion of patients with newly diagnosed fulminant T1D (FT1DM) and acute onset T1D (AT1DM), suggesting that autoantibodies to HSP10 are new diagnostic and clinical markers of T1D (25). Here, HSPE1 is linked to type 1 diabetes mellitus.